Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
ADMA Biologics Inc (ADMA) had Stock-Based Compensation of $12.46M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$124.39M |
|
$37.82M |
|
$38.12M |
|
$86.28M |
|
$71.95M |
|
$52.45M |
|
$-2.21M |
|
$50.24M |
|
$50.24M |
|
$37.82M |
|
$37.82M |
|
$37.82M |
|
$37.82M |
|
$52.45M |
|
$54.38M |
|
228.23M |
|
230.34M |
|
$0.17 |
|
$0.16 |
|
| Balance Sheet Financials | |
$528.20M |
|
$66.66M |
|
$156.01M |
|
$684.21M |
|
$75.76M |
|
$198.91M |
|
$200.25M |
|
$276.00M |
|
$408.21M |
|
$404.10M |
|
$408.21M |
|
225.35M |
|
| Cash Flow Statement Financials | |
$87.79M |
|
$0.15M |
|
$-39.55M |
|
$87.63M |
|
$136.02M |
|
$48.39M |
|
|
Stock-Based Compensation |
$12.46M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.97 |
|
-- |
|
-- |
|
0.33 |
|
0.50 |
|
69.36% |
|
42.16% |
|
42.16% |
|
-- |
|
40.39% |
|
30.40% |
|
$82.99M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.16 |
|
0.90 |
|
100.01 |
|
9.27% |
|
9.36% |
|
5.53% |
|
6.23% |
|
$1.81 |
|
$0.36 |
|
$0.38 |
|